Podcast: Key considerations for establishing or enhancing a patent monitoring programme

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Podcast: Key considerations for establishing or enhancing a patent monitoring programme

Sponsored by

Logo 22.07.22.png
CAS2_4x.png

Matt Garver and Peter Mattei of CAS explain what information companies should be getting from patent monitoring programmes

In this episode, the second of a two-part series sponsored by CAS, we focus on the key considerations for establishing or enhancing a patent monitoring programme.



Matt Garver, IP search analyst at CAS, and Peter Mattei, senior IP searcher at CAS, are joined Managing IP's senior reporter Rani Mehta to discuss:

  • How do you determine what information you should be getting?

  • How do you act on the information?

  • How do you evaluate a programme’s success?


About CAS

CAS connects the world’s scientific knowledge to accelerate breakthroughs that improve lives. It empowers global innovators to efficiently navigate today’s complex data landscape and make confident decisions in each phase of the innovation journey.

As a specialist in scientific knowledge management, the team builds the largest authoritative collection of human-curated scientific data in the world and provides essential information solutions, services, and expertise. Scientists, patent professionals, and business leaders across industries rely on CAS to help them uncover opportunities, mitigate risks, and unlock shared knowledge so they can get from inspiration to innovation faster. CAS is a division of the American Chemical Society.

more from across site and SHARED ros bottom lb

More from across our site

Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Gift this article